Early ILD Progression in Systemic Sclerosis Linked to Higher Mortality, Not Continued Lung Decline: Study Suggests
Norway: A recent multicentre observational cohort study published in The Lancet Rheumatology offers new insights into disease progression patterns in patients with systemic sclerosis-associated interstitial lung disease (ILD). The study,…
